Latest filing published 30 Jun 2021 for Stoke Therapeutics, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
ATP Life Science Ventures, L.P.: trading record in brief
This profile gathers the share dealings of ATP Life Science Ventures, L.P. across 2 companies, led by Akero Therapeutics, Inc. and Stoke Therapeutics, Inc. We count 2 filings, every one of them for a trade on 28 June 2021.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 30 June 2021 with a transaction in Stoke Therapeutics, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to ATP Life Science Ventures, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 17,161,713 sharesCommon StockSEC:0001062993-21-006113:0
- 5,830,203 sharesCommon StockSEC:0001062993-21-006112:0
2 of 2 declarations
